Results per Page:
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos
De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
Timing of ART administration for HIV is more important than we thought
From the Edlefsen and Frenkel Groups, Cancer Consortium
Using mathematical models to tell time of initial HIV infection in infants
From the Overbaugh/Lehman Lab, Cancer Consortium and Human Biology Division
The unintended immune consequences of HIV treatments
From the Hladik Lab, Vaccine and Infectious Disease Division
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Models identify cellular proliferation as driver of HIV persistence
From the Schiffer group, Vaccine and Infectious Disease Division
Despite early rise, longterm ART decreases HSV shedding
From the Corey lab, Vaccine and Infectious Disease Division
Hutch researcher, South African pediatrician recalls HIV hero Nkosi Johnson at AIDS 2016
At AIDS 2016, a South African pediatrician and Fred Hutch vaccine researcher pays tribute to a young HIV hero
Charlie Sheen’s announcement reveals ‘ugly ogre underneath’ public awareness of HIV
Reactions underscore disease’s lingering stigma
SCHARP played key role in scientific breakthrough of the year
Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent
Study details how long-term nonprogressors control HIV
Local collaborative research has far-reaching implications for autoimmunity, chronic infection control